Organon is a renowned global biopharmaceutical company committed to improving the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of our core therapeutic fields: fertility, gynecology and selected areas of anesthesia. In addition, we have extensive experience in neuroscience, and we conduct research in immunology and oncology. Our products are distributed in over 100 countries, of which more than 50 have an Organon subsidiary. Organon is the human health care business unit of Akzo Nobel.